Variation of reduction factor VIII, together with CpG, components and methods of hemophilia and treatment

摘要

It refers to the nucleic acid variant encoded by factor 8 (FVII), which has the boundary of domain B, in which the nucleic acid variant and SEC No.: 7 have the characteristics of 92% to 100%; in this factor, the nucleic acid variant contains 20% or less citosina guanidine (CPG). He also mentioned that a specific expression vector consists of a gland related viral vectorAn antiretroviral vector, an adenosine vector, a plasticizer or a slow vector, a hollow cell, and a pharmacological component, including a variant of this nucleic acid, are effective ways to treat disorders associated with abnormal hemophilia.